Using injectable platelet-rich fibrin with bovine bone grafts to treat intrabony periodontal defects
Official title: Evaluation of the Effect of Injectable Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects With Xenogenic Grafts: a Randomized Controlled Clinical Trial
Run by Saglik Bilimleri Universitesi · NCT07146776 · Data updated 2026-11-12
This will try adding injectable platelet-rich fibrin (i-PRF) to bovine bone grafts to see if adults with stage III periodontitis and intrabony defects heal better than with grafts alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Istanbul, Üsküdar) |
| Status | Recruiting |
| Started | July 12, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07146776 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with stage III periodontitis who have interproximal 2- or 3-walled intrabony defects ≥3 mm and persistent probing depths ≥5 mm after initial therapy, and who are non-smokers or light smokers (≤10 cigarettes/day).
✕Probably not a fit
People with single-walled defects, uncontrolled systemic disease (such as uncontrolled diabetes), heavy smokers, those recently on antibiotics or with recent periodontal surgery, and pregnant or breastfeeding patients are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with stage III periodontitis and interproximal intrabony defects will undergo open flap debridement and receive either bovine-derived xenogenic bone graft mixed with i-PRF or the same graft mixed with saline. Clinical measures (for example probing pocket depth and defect area) and radiographic bone fill will be recorded and compared between the two groups. The aim is to determine whether i-PRF increases bone fill and reduces defect size versus graft alone. Findings will show whether adding this tissue-friendly biologic improves commonly used bovine xenograft outcomes for intrabony defects.
Why it matters
Potential benefit: If successful, adding i-PRF could increase bone fill and reduce pocket depths and defect size, improving periodontal healing after surgery.
How similar studies have gone: Previous studies combining PRF derivatives with various graft materials have shown promising results, but the specific combination of i-PRF with bovine-derived xenograft for intrabony defects has not been studied before.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female patients aged 18-65 years * Patients with Stage III Periodontitis according to the AAP-EFP 2017 Periodontal Disease Classification * PPD≥5 mm (if persistent 6 weeks after initial periodontal treatment) * Intrabony defects in the interproximal region with 2 or 3 walls and a depth of at least ≥3 mm * Non-smokers (those who smoke up to 10 per day may be included) Exclusion Criteria: * Patients under 18 years of age or older than 65 years of age * Patients unable to consent * Systemic diseases that could affect the success of surgery, such as uncontrolled diabetes * Single-walled intrabony defects * Those who have taken antibiotics, anti-inflammatory or immunosuppressive drugs, or birth control pills within the three months prior to the study * Those who have received active periodontal treatment within the last six months and periodontal surgery within the last year * Smoking more than 10 cigarettes per day * Pregnancy or breastfeeding * Those taking medications that affect the gums (e.g., calcium channel blockers, phenytoin or cyclosporine) * Teeth with furcation defects * Those undergoing active orthodontic treatment * Those who are allergic to the biomaterials used in the study or prescribed medications
Where it's running
-
Sağlık Bilimleri Üniversitesi
Istanbul, Üsküdar, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Tuğçe Paksoy, Associate Professor
- Email: tugceakap86@hotmai.com
- Phone: +905534490452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if periodontal treatment improves chewing ability and oral quality of life
This study tests whether treating periodontitis improves how well people can chew and how they feel about their oral health.
-
Candida albicans and periodontitis in Syrian patients
This project will test whether Candida albicans is commonly present in the gum pockets of Syrian adults with chronic periodontitis.
-
JAK1 and JAK2 activation in healthy versus inflamed gums
We will test whether the JAK1 and JAK2 immune-signaling pathways are more active in adults with periodontitis than in adults with healthy gums.
-
Online self-check to identify your gum disease risk and guide preventive care
This project will test whether an online questionnaire can accurately identify gum disease risk in adults with natural teeth.
-
Blood and saliva markers to track gum disease and healing after non-surgical cleaning
This project tries to see if a blood score (HALP), other blood inflammation markers, and salivary MMP-8 can help identify gum disease stage and predict healing after non-surgical periodontal cleaning in adults aged 18–65.
-
Lovastatin gel under the gum plus deep cleaning for periodontitis in smokers and non-smokers
This test sees if placing a 1.2% lovastatin gel under the gum after deep cleaning helps adults with periodontitis, comparing smokers and non-smokers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.